Onset of Autoimmune Hepatitis During Intravenous Steroid Therapy for Thyroid-Associated Ophthalmopathy in a Patient with Hashimoto's Thyroiditis: Case Report-Reference-Cited by-同舟云学术

Onset of Autoimmune Hepatitis During Intravenous Steroid Therapy for Thyroid-Associated Ophthalmopathy in a Patient with Hashimoto's Thyroiditis: Case Report

Published:2004-08 Issue:8 Volume:14 Page:631-634
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Salvi Mario¹,Vannucchi Guia¹,Sbrozzi Francesco²,Del Castello Alessandra Bottari²,Carnevali Alessandra³,Fargion Silvia⁴,Beck-Peccoz Paolo¹

Affiliation:

1. Institute of Endocrine Sciences, Ospedale IRCCS, University of Milan, Milan, Italy.

2. Institute of Ophthalmology, Ospedale IRCCS, University of Milan, Milan, Italy.

3. Institute of Radiology, Ospedale IRCCS, University of Milan, Milan, Italy.

4. Institute of Internal Medicine, Ospedale IRCCS, University of Milan, Milan, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/1050725041692927

Reference13 articles.

1. Management of Graves' Ophthalmopathy: Reality and Perspectives

2. Diagnosis and treatment of autoimmune hepatitis

3. Comparison of the Effectiveness and Tolerability of Intravenous or Oral Glucocorticoids Associated with Orbital Radiotherapy in the Management of Severe Graves' Ophthalmopathy: Results of a Prospective, Single-Blind, Randomized Study

4. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy

5. Treatment of Graves' ophthalmopathy with high-dose intravenous methylprednisolone pulse therapy

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Therapeutic Options in Active Moderate-to-Severe Thyroid-Associated Ophthalmopathy;Acta Medica Bulgarica;2023-12-01

2. Comparison of the efficacy of two different glucocorticoid regimens for treatment of active moderate-to-severe Graves’ orbitopathy;International Ophthalmology;2023-09-12

3. Optimization of the treatment of moderate to severe and active thyroid orbitopathy considering the recommendations of the European Group on Graves’ Orbitopathy (EUGOGO) [Optymalizacja leczenia umiarkowanej do ciężkiej i aktywnej orbitopatii tarczycowej z uwzględnieniem zaleceń European Group on Graves’ Orbitopathy (EUGOGO)];Endokrynologia Polska;2022-08-17

4. Bone marrow fibrocytes: villain or white knight in thyroid-associated ophthalmopathy?;Current Opinion in Endocrinology, Diabetes & Obesity;2022-08-11

5. Methylprednisolone-related liver injury: A descriptive study using the French pharmacovigilance database;Clinics and Research in Hepatology and Gastroenterology;2020-10